Immunoresponse to Wilms Tumor antigen-1 (WT-1) in CML patients.

Immunoresponse to Wilms Tumor antigen-1 (WT-1) in CML patients.

Bibliographic Details
Main Authors:	Bellantuono, I, Macchiarulo, E, Gao, L, Dazzi, F, Cerundolo, V, Marley, S, Gordon, M, Goldman, J, Stauss, H
Format:	Journal article
Published:	2000

Similar Items

Wilms’ Tumor 1 (WT1): The Vaccine for Cancer
by: Kyaw Zaw Hein, et al.
Published: (2020-11-01)

Wilms Tumor-1 (WT1) rs16754 Polymorphism
by: Pathum Sookaromdee, et al.
Published: (2019-02-01)

Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.
by: Ayana E Morales, et al.
Published: (2024-01-01)

Implications of the Wilms’ Tumor Suppressor Wt1 in Cardiomyocyte Differentiation
by: Nicole Wagner, et al.
Published: (2021-04-01)

Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy
by: Seyed Mostafa Monzavi, et al.
Published: (2023-09-01)

Every Beat You Take—The Wilms′ Tumor Suppressor WT1 and the Heart
by: Nicole Wagner, et al.
Published: (2021-07-01)

Inhibitory effect of curcuminoids on Wilms' tumor1 (WT1) gene and its protein expression
by: S Tima, et al.
Published: (2008-01-01)

Studies of Wilms’ Tumor (WT1) Gene Expression in Adult Acute Leukemias in Singapore
by: Che Kang Lim, et al.
Published: (2007-01-01)

Design of an Optimized Wilms’ Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo
by: Daphné Benteyn, et al.
Published: (2013-01-01)

Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141+ dendritic cells to activate naïve and memory WT1‐specific CD8+ T cells
by: Frances E Pearson, et al.
Published: (2020-01-01)

Wilms Tumor-1 (WT1) rs16754 Polymorphism and Clinical Outcome in Acute Myeloid Leukemia
by: Mani Ramzi, et al.
Published: (2019-02-01)

Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
by: Ochsenreither Sebastian, et al.
Published: (2010-01-01)

A Pathologic Link between Wilms Tumor Suppressor Gene, WT1, and IFI16
by: Marianne K-H. Kim, et al.
Published: (2008-01-01)

ยีนวิล์มทูเมอร์วัน (Wilms’ tumor 1 gene or WT1) กับการเกิดมะเร็งเม็ดเลือดขาว Wilms’ tumor 1 gene and leukemogenesis
by: ทรงยศ อนุชปรีดา, et al.
Published: (2015-02-01)

The Wilms Tumor Gene wt1a Contributes to Blood-Cerebrospinal Fluid Barrier Function in Zebrafish
by: Vera L. Hopfenmüller, et al.
Published: (2022-01-01)

Expression of inhibin-alpha is regulated synergistically by Wilms' tumor gene 1 (Wt1) and steroidogenic factor-1 (Sf1) in sertoli cells.
by: Shao-Yang Ji, et al.
Published: (2013-01-01)

<i>TERT</i> Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYC
by: Carolyn M. Jablonowski, et al.
Published: (2022-03-01)

Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different <i>WT1</i> Mutations
by: Brigitte Royer-Pokora, et al.
Published: (2020-12-01)

Oxygen-dependent gene expression in development and cancer: lessons learned from the Wilms’ tumor gene, WT1
by: Holger eScholz, et al.
Published: (2011-02-01)

Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms’ Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49)
by: Dorin Novacescu, et al.
Published: (2022-04-01)

Immunoresponse to Gene-Modified Hematopoietic Stem Cells
by: Claire M. Drysdale, et al.
Published: (2020-03-01)

WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE
by: Miwako Narita, Masayoshi Masuko, Tohri Kurasaki, Toshiki Kitajima, Shoko Takenouchi, Anri Saitoh, Norihiro Watanabe, Tatsuo Furukawa, Ken Toba, Ichiro Fuse, Yoshifusa Aizawa, Manabu Kawakami, Yoshihiro Oka, Haruo Sugiyama, Masuhiro Takahashi
Published: (2010-01-01)

The Role of Wilms’ Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia
by: Davide Lazzarotto, et al.
Published: (2022-06-01)

Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1
by: Kay-Dietrich Wagner, et al.
Published: (2019-01-01)

Mutational spectrum of <it>WTX</it>, <it>WT1</it>, <it>CTNNB1</it>, <it>APC</it> and <it>PLCG2</it> genes in Wilms tumor defined by massive parallel resequencing
by: Barros Bruna D, et al.
Published: (2012-10-01)

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency
by: Lahman, MC, et al.
Published: (2022)

High Expression of WT1 and Low Expression of p53 in Archived Blocks of Children with Wilms Tumor in South Western Uganda
by: Ssenkumba B, et al.
Published: (2024-03-01)

Molecular mechanism of Wilms’ tumor (Wt1) (+/−KTS) variants promoting proliferation and migration of ovarian epithelial cells by bioinformatics analysis
by: Xiaomei Wang, et al.
Published: (2023-02-01)

Bilateral Wilms′ tumors in an infant with Denys-Drash syndrome and rarely seen truncation mutation in the WT1 gene-exon 6
by: Jayesh Modi, et al.
Published: (2015-01-01)

Immunoreactivity of Wilms tumor 1 (WT1) as an additional evidence supporting hemangiomatous rather than inflammatory origin in the etiopathogenesis of angiolymphoid hyperplasia with eosinophilia
by: Fatma Tokat, et al.
Published: (2018-01-01)

Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms
by: A El-Sayed
Published: (2018-04-01)

Wilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line.
by: Rosalba Parenti, et al.
Published: (2014-01-01)

Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice
by: Rachel L. Berry, et al.
Published: (2015-08-01)

Alteration in DNA-binding affinity of Wilms tumor 1 protein due to WT1 genetic variants associated with steroid - resistant nephrotic syndrome in children
by: Martin Bezdicka, et al.
Published: (2022-05-01)

Corrigendum: Methylation Statuses of H19DMR and KvDMR at WT2 in Wilms Tumors in Taiwan
by: Meng-Yao Lu, et al.
Published: (2022-08-01)

Influence of Maqian essential oil on gut microbiota and immunoresponses in type 1 diabetes: In silico study
by: Mahmoud Dahab, et al.
Published: (2024-04-01)

The Wilms tumor gene, Wt1, is critical for mouse spermatogenesis via regulation of sertoli cell polarity and is associated with non-obstructive azoospermia in humans.
by: Xiao Na Wang, et al.
Published: (2013-01-01)

Wilm’s tumor 1 promotes memory flexibility
by: Chiara Mariottini, et al.
Published: (2019-08-01)

Evaluation of immunoresponses and cytotoxicity from skin exposure to metallic nanoparticles
by: Wang M, et al.
Published: (2018-08-01)

Heterologous expression of Mus musculus immunoresponsive gene 1 (irg1) in Escherichia coli results in itaconate production
by: Kiira S Vuoristo, et al.
Published: (2015-08-01)